^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    IBI-389

    i
    Other names: IBI-389, IBI389, IBI 389
    Associations
    News
    Trials
    Company:
    Innovent Biologics
    Drug class:
    CD3 agonist, CLDN18.2 inhibitor
    Related drugs:
    Associations
    News
    Trials